Christelle Ansaldi Selected Research

Christelle Ansaldi Research Topics

Disease

4	Fibrosis (Cirrhosis) 01/2021 - 01/2011
2	Cholangiocarcinoma 01/2022 - 12/2019
2	Neoplasms (Cancer) 01/2022 - 12/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 01/2011
2	Infections 01/2015 - 02/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Chronic Hepatitis C 01/2015
1	Hepatitis C 01/2015

Drug/Important Bio-Agent (IBA)

2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2022 - 01/2020
1	Ammonium Chloride (Sal Ammoniac)FDA Link 01/2022
1	Cathepsin BIBA 01/2022
1	Cathepsin DIBA 01/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	Cathepsin LIBA 01/2022
1	isothiocyanic acidIBA 01/2022
1	bafilomycin A1IBA 01/2022
1	N-tert-butylhydroxylamineIBA 01/2022
1	palmitoyl-protein thioesteraseIBA 01/2022
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 01/2022
1	phosphatidylethanolamineIBA 01/2022
1	ZincIBA 01/2022
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2022
1	Annexin A5IBA 01/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2022
1	Cyclin D1IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Lysosomal Membrane ProteinsIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Caspase 7IBA 01/2022
1	Caspase 8 (Caspase-8)IBA 01/2022
1	carbobenzoxyphenylalanineIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	Bovine Serum AlbuminIBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2021
1	CollagenIBA 01/2020
1	CaspasesIBA 12/2019
1	SofosbuvirIBA 01/2015
1	ledipasvirIBA 01/2015
1	TabletsIBA 01/2015
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 02/2014
1	Antiviral Agents (Antivirals)IBA 01/2014

Therapy/Procedure

4	Therapeutics 12/2019 - 01/2011
1	Lasers (Laser) 01/2022
1	Oral Administration 01/2020